View source for Savior sibling technology for rejuvenation

'''Savior sibling technology for rejuvenation''' was originally developed in 2004 by Anver Kuliev & Yury Verlinsky.<ref>Kuliev A. & Verlinsky Y. (2004). Preimplantation HLA typing and stem cell transplantation: report of International Meeting, Cyprus, 27–28 March, PMID: 15354311 [https://www.rbmojournal.com/article/S1472-6483(10)62131-1/pdf DOI: 10.1016/s1472-6483(10)62131-1]</ref><ref>Kuliev, A., Rechitsky, S., TUR‐KASPA, I. L. A. N., & Verlinsky, Y. (2005). Preimplantation genetics: improving access to stem cell therapy. Annals of the New York Academy of Sciences, 1054(1), 223-227.  PMID: 16339669 [https://doi.org/10.1196/annals.1345.028 DOI: 10.1196/annals.1345.028]</ref>
A savior baby or savior sibling is a child who is conceived using '''preimplantation genetic diagnosis''' (PGD) in order to provide multiple times a stem cell transplant to a sibling that needs rejuvenation through cell therapy.<ref>Tian, Y., Li, M., Yang, J. et al. (2024). Preimplantation genetic testing in the current era, a review. Arch Gynecol Obstet. PMID: 38376520 [https://doi.org/10.1007/s00404-024-07370-z DOI: 10.1007/s00404-024-07370-z]</ref>  Stem cell transplants and exosomes are regularly isolated from donor urine.<ref>Dan, Q. Q., Chen, L., Shi, L. L., Zhou, X., Wang, T. H., & Liu, H. (2023). Urine-derived mesenchymal stem cells-derived exosomes enhances survival and proliferation of aging retinal ganglion cells. BMC Molecular and Cell Biology, 24(1), 8. PMID: 36879194 PMCID: PMC9990288 DOI: 10.1186/s12860-023-00467-4</ref><ref>Cavaleiro, C., Afonso, G. J., Oliveira, P. J., Valero, J., Mota, S. I., & Ferreiro, E. (2023). Urine-derived stem cells in neurological diseases: current state-of-the-art and future directions. Frontiers in Molecular Neuroscience, 16. PMID: 37965041 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642248/ PMC10642248] DOI: 10.3389/fnmol.2023.1229728</ref><ref>Yu, P., Bosholm, C. C., Zhu, H., Duan, Z., Atala, A., & Zhang, Y. (2024). Beyond waste: understanding urine’s potential in precision medicine. Trends in Biotechnology. PMID: 38369434 [https://doi.org/10.1016/j.tibtech.2024.01.009 DOI: 10.1016/j.tibtech.2024.01.009]</ref><ref>Rao, S., He, Z., Wang, Z., Yin, H., Hu, X., Tan, Y., ... & Chen, C. (2024). Extracellular vesicles from human urine-derived stem cells delay aging through the transfer of PLAU and TIMP1. Acta Pharmaceutica Sinica B, 14(3), 1166-1186. https://doi.org/10.1016/j.apsb.2023.12.009</ref>

== References ==
<references />
[[Category:Main list]]
[[Category:Lifespan interventions]]